Wael Fayad serves as Executive at Enumeral Biomedical Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Wael Fayad has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 9, 2016 involved exercising options for 298,000 shares valued at $38.7K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 9, 2016 | ENUM | $38.7K | Option Exercise | 298,000 | $0.13 | Discretionary |
Wael Fayad currently holds 298,000 shares of Enumeral Biomedical Holdings, Inc. (ENUM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wael Fayad has been a net neutral trader of ENUM stock. They have purchased $0 and sold $0 worth of shares.
Wael Fayad's most recent insider trade was on Dec 9, 2016, when they sold 298,000 shares at $0.13 per share.
Get notified when new Form 4 filings are submitted